How fast does semaglutide kick in — and what happens first?

Step 1 — The first injection to week four: what the body is adjusting to

Semaglutide reaches measurable plasma levels within 24 to 48 hours of the first injection. The pharmacology is straightforward: it activates GLP-1 receptors in the gut and brain, slowing how quickly the stomach empties and reducing appetite signals. You will not feel this happening in a dramatic way on day one. What most people report in the first week or two is a quieter internal pull towards food, fewer strong cravings, smaller portions feeling more satisfying. Some notice nothing at all initially, which is entirely normal at the starter dose.

The 0.25 mg starting dose is there so your system can adjust, not to drive weight loss. Nausea is the most common early side effect, and starting low keeps it manageable. If you order on a Monday before the cut-off, your first pen arrives Tuesday, then four weeks of once-weekly injections before your prescriber considers moving you up. The ten-week results picture gives a useful reference point for what is realistic by that stage.

By week four, some people have already lost one to two kilograms. Others have lost less. Both are within the expected range. The prescriber's job at this point is to weigh up tolerability and early response before recommending a dose increase.

Step 2, Weeks four to twelve: the titration window where most people feel the shift

This is the stretch most people describe as the turning point. The dose rises from 0.25 mg to 0.5 mg, then often to 1.0 mg over successive four-week steps, and appetite suppression becomes more pronounced with each increase. Gastric emptying slows further; fullness arrives earlier in a meal and stays longer. Cravings for high-calorie foods often reduce more noticeably here than they did at the starting dose.

Clinical trial data from the STEP 1 study, published in the New England Journal of Medicine, found that participants using semaglutide 2.4 mg lost an average of around 15% of body weight over 68 weeks. That overall figure is the product of gradual, compounding loss across this titration window and beyond, not a fast drop at the beginning. Weeks four to twelve tend to account for a disproportionate share of early progress as the dose climbs and the lifestyle changes bed in.

If you are comparing notes with someone else on a different GLP-1 medicine, a full overview of how Wegovy works explains the semaglutide mechanism in more depth. Results at this stage still vary considerably between individuals, and a prescriber is better placed than any timeline to interpret your specific response.

Step 3, Month three onwards: when semaglutide's effect reaches its full pace

By week 12 to 16 most people are at the 1.7 mg dose or approaching the 2.4 mg maintenance level. This is where the rate of weight loss often peaks before settling into a steadier pattern. The body has adapted to the medicine; the appetite suppression is consistent rather than intermittent; and dietary habits formed in the earlier weeks are producing cumulative results.

There is a practical cost angle worth knowing at this point. Treatment runs for months, not weeks, so understanding the full picture of what is included in a prescription service matters. The cost of Wegovy in the UK page sets out how private pricing works and what to look for in a transparent provider. For the NHS route, the NHS's semaglutide medicine guide covers the access context and what ongoing monitoring involves.

A small group of people do not respond as expected even at the maintenance dose. NICE guidance on semaglutide notes that if weight loss is less than 5% after six months at the maintenance dose, continuing should be reviewed with the prescriber. That is not a failure, it is a clinical signal that a different approach may suit better. Our prescribers have that conversation regularly. It is one our clinical team, including our lead prescriber, takes seriously in every review.

Step 4, Longer-term: sustaining what semaglutide started

Weight loss tends to plateau for most people somewhere between month nine and month fifteen, as the body reaches a new equilibrium. This plateau is not a sign the medicine has stopped working; it reflects normal physiology. At 2.4 mg maintenance, continued treatment preserves the loss and (with the lifestyle work alongside) can push it further over time.

From 14 April 2026, the MHRA also approved a 7.2 mg semaglutide pen for adults with a BMI of 30 or above. Trial data suggested around 20.7% average weight loss at 7.2 mg over 72 weeks, narrowing the gap with the highest tirzepatide dose. Whether that dose is appropriate is a clinical decision, not something to self-select into. The prescriber reviewing your case will know if the evidence supports it for you.

Questions about the broader timeline? The how long for semaglutide to kick in page goes deeper on the pharmacokinetics, and our guide on Wegovy's onset addresses brand-specific questions. If you are ready to explore whether treatment is clinically suitable for you, start with a free consultation with our prescribers.